https://www.aibioos.com/en/ Updates from AIBIOOS Academic Publications, Latest Insights, and Research Topics. en-US Fri, 17 Jul 2026 00:00:00 GMT https://www.aibioos.com/en/insights/#insight-nature-medicine-2026-07-17 Researchers have developed an AI assistant, called Biomni, to perform research tasks across diverse biomedical fields. With further training and optimization, Biomni could be a powerful research partner for scientists. Source: Nature Medicine. Original link: https://www.nature.com/articles/d41591-026-00037-z Fri, 17 Jul 2026 00:00:00 GMT aibioos:insight:nature-medicine-2026-07-17:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-medicine-2026-07-16 Researchers used immunopeptidomics to identify conserved Plasmodium T cell antigens, revealing potential for cross-stage, cross-species malaria vaccine development. Source: Nature Medicine. Original link: https://www.nature.com/articles/d41591-026-00036-0 Thu, 16 Jul 2026 00:00:00 GMT aibioos:insight:nature-medicine-2026-07-16:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-medicine-2026-07-16 Combining the CD19–4-1BBL co-stimulatory molecule englumafusp alfa with the bispecific antibody glofitamab in patients with relapsed or refractory aggressive B cell non-Hodgkin lymphoma showed acceptable safety signals and encouraging preliminary clinical responses, with mechanistic data supporting the rational choice of therapy. Source: Nature Medicine. Original link: https://www.nature.com/articles/s41591-026-04533-0 Thu, 16 Jul 2026 00:00:00 GMT aibioos:insight:nature-medicine-2026-07-16:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-medicine-2026-07-16 Scientists developed a bidirectional sensorimotor neuroprosthetic system that decodes brain signals associated with movement intention while delivering patterned neuromodulation to the spinal cord and cortex. This system provides long-term recovery of hand motor and sensory function, even when the device is off. Source: Nature Medicine. Original link: https://www.nature.com/articles/s41591-026-04498-0 Thu, 16 Jul 2026 00:00:00 GMT aibioos:insight:nature-medicine-2026-07-16:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-biotechnology-2026-07-15 Scientists used a triple-reporter mouse to image tumors across scales—from cells to whole body. Source: Nature Biotechnology. Original link: https://www.nature.com/articles/s41587-026-03184-3 Wed, 15 Jul 2026 00:00:00 GMT aibioos:insight:nature-biotechnology-2026-07-15:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-biotechnology-2026-07-15 Scientists developed an event-based first-photon fluorescence lifetime imaging technique that enables fluorescence lifetime imaging below one photon per pixel. Source: Nature Biotechnology. Original link: https://www.nature.com/articles/s41587-026-03222-0 Wed, 15 Jul 2026 00:00:00 GMT aibioos:insight:nature-biotechnology-2026-07-15:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-biotechnology-2026-07-15 Scientists developed a high-numerical-aperture confocal volumetric mesoscope that reveals subcellular immune dynamics in different mammalian organs. Source: Nature Biotechnology. Original link: https://www.nature.com/articles/s41587-026-03231-z Wed, 15 Jul 2026 00:00:00 GMT aibioos:insight:nature-biotechnology-2026-07-15:en Latest Insights https://www.aibioos.com/en/insights/#insight-nature-biotechnology-2026-07-15 Scientists developed a single-nucleotide-resolution adenine base editor (snuABE) that uses ADAR and customized guide RNAs to precisely convert adenines to guanines on DNA targets with minimal bystander editing. Source: Nature Biotechnology. Original link: https://www.nature.com/articles/s41587-026-03228-8 Wed, 15 Jul 2026 00:00:00 GMT aibioos:insight:nature-biotechnology-2026-07-15:en Latest Insights https://www.aibioos.com/en/publications/microplastics-entering-life-systems/ This review traces the discovery pathway of microplastics entering living systems, summarizes ecological and human evidence, evaluates potential health and ecological threats, and reviews policy responses in the United States, Canada, the United Kingdom, China, the European Union, and the United Nations, arguing for scientifically restrained but proactive exposure reduction, material substitution, standardized monitoring, and full-life-cycle governance. Thu, 02 Jul 2026 00:00:00 GMT https://www.aibioos.com/en/publications/microplastics-entering-life-systems/ Academic Publications https://www.aibioos.com/en/publications/obesity-gut-microbiota-relationship/ Based on publicly searchable evidence from Nature, Science, Cell, Nature Medicine, Cell Metabolism, PNAS, WHO, and related sources, this review evaluates the scientific relationship between obesity and the gut microbiota, arguing that its value lies in explaining metabolic variability and improving long-term intervention precision rather than serving as a single weight-loss answer. Mon, 29 Jun 2026 00:00:00 GMT https://www.aibioos.com/en/publications/obesity-gut-microbiota-relationship/ Academic Publications https://www.aibioos.com/en/publications/copper-peptides-anti-hair-loss-cosmetics/ Based on searchable international literature, this article reviews the direct follicle-related evidence, mechanistic rationale, delivery limits, and regulatory boundaries of copper peptides in anti-hair-loss cosmetics, concluding that they are better positioned as supportive follicular-microenvironment actives than as substitutes for drug therapy. Wed, 17 Jun 2026 00:00:00 GMT https://www.aibioos.com/en/publications/copper-peptides-anti-hair-loss-cosmetics/ Academic Publications https://www.aibioos.com/en/publications/nanoceria-follicular-rejuvenation-cosmetic-actives/ This publication reviews mechanism-level evidence for cosmetic actives targeting hair loss and graying, and proposes the Nanoceria-Assisted Follicular Rejuvenation Model as a testable redox-centered research hypothesis. Thu, 11 Jun 2026 00:00:00 GMT https://www.aibioos.com/en/publications/nanoceria-follicular-rejuvenation-cosmetic-actives/ Academic Publications https://www.aibioos.com/en/publications/hair-pigment-loss-hair-loss-asian-populations/ This review summarizes multifactorial causes of hair depigmentation and hair loss in Asian populations and discusses non-pharmacological strategies including nutrition, stress management, scalp care, low-level light therapy, PRP, and functional ingredients. Thu, 11 Jun 2026 00:00:00 GMT https://www.aibioos.com/en/publications/hair-pigment-loss-hair-loss-asian-populations/ Academic Publications https://www.aibioos.com/en/insights/#insight-fda-year-1-animal-testing FDA reported first-year progress on its roadmap to reduce animal testing in drug development, including advanced in vitro systems, computational modeling, and human-relevant platforms. The signal points to a regulatory shift from single-model dependence toward evidence systems with stronger interpretability, reproducibility, and human relevance. Source: FDA. Original link: https://www.fda.gov/news-events/press-announcements/fda-achieves-year-1-goals-reducing-animal-testing-drug-development Mon, 20 Apr 2026 00:00:00 GMT aibioos:insight:fda-year-1-animal-testing:en Latest Insights https://www.aibioos.com/en/insights/#insight-fda-draft-guidance-nams FDA issued draft guidance on validating alternatives to animal testing, clarifying how new approach methodology data may be submitted, validated, and interpreted in drug development. The key point is that alternatives must demonstrate data quality, scope of use, and regulatory acceptability, not merely reduce animal use. Source: FDA. Original link: https://www.fda.gov/news-events/press-announcements/fda-releases-draft-guidance-alternatives-animal-testing-drug-development Wed, 18 Mar 2026 00:00:00 GMT aibioos:insight:fda-draft-guidance-nams:en Latest Insights https://www.aibioos.com/en/insights/#insight-nvidia-bionemo NVIDIA reported expanded adoption of BioNeMo across life science use cases, reflecting growing reliance on foundation models, accelerated computing, and composable AI workflows in drug discovery. The relevant shift is infrastructure-level: connecting molecular modeling, data engineering, experimental design, and team collaboration. Source: NVIDIA Newsroom. Original link: https://nvidianews.nvidia.com/news/nvidia-bionemo-platform-adopted-by-life-sciences-leaders-to-accelerate-ai-driven-drug-discovery Thu, 01 Jan 2026 00:00:00 GMT aibioos:insight:nvidia-bionemo:en Latest Insights https://www.aibioos.com/en/insights/#insight-nih-organoid-center NIH Record described an organoid development center combining standardized organoid models, AI, robotics, shared cell resources, and reproducible workflows. For life science platforms, the signal is infrastructure-oriented: linking model construction, data capture, and laboratory automation to improve scalability and comparability. Source: NIH Record. Original link: https://nihrecord.nih.gov/2025/12/05/nih-establishes-organoid-development-center Fri, 05 Dec 2025 00:00:00 GMT aibioos:insight:nih-organoid-center:en Latest Insights https://www.aibioos.com/en/insights/#insight-fda-agentic-ai FDA announced broader internal deployment of agentic AI capabilities to support scientific, review, and operational workflows. The signal is institutional rather than merely technical: AI adoption in life science settings increasingly requires workflow governance, accountability boundaries, auditability, and human review. Source: FDA. Original link: https://www.fda.gov/news-events/press-announcements/fda-expands-artificial-intelligence-capabilities-agentic-ai-deployment Mon, 01 Dec 2025 00:00:00 GMT aibioos:insight:fda-agentic-ai:en Latest Insights https://www.aibioos.com/en/insights/#insight-alphafold-impact Google DeepMind reviewed AlphaFold's long-term impact, positioning protein structure prediction as a foundational capability in digital biology. Its importance extends beyond prediction accuracy, reshaping how researchers formulate questions, infer mechanisms, screen candidates, and organize AI-enabled discovery workflows. Source: Google DeepMind. Original link: https://deepmind.google/blog/alphafold-five-years-of-impact/ Sat, 01 Nov 2025 00:00:00 GMT aibioos:insight:alphafold-impact:en Latest Insights